RAND Corporation and the Moran Company issued reports discussing the cost savings associated with biosimilars.
The event will take place on November 21 in Basel.
In Cameroon, seeking treatment for chronic diseases can be a long journey.
Cameroon faces a serious increase in chronic diseases like heart disease, asthma, cancer and diabetes. This agreement complements the government’s ongoing efforts by improving access to affordable medicines and educating patients.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.